Informações:
Falhas:
ID
38755
Descrição
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01652716
Link
https://clinicaltrials.gov/show/NCT01652716
Palavras-chave
Versões (1)
- 31/10/2019 31/10/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
31 de outubro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes Mellitus, Type 2 NCT01652716
Eligibility Diabetes Mellitus, Type 2 NCT01652716
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT01652716
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
at least 18 years old
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
diagnosed with type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c 7.1 to 11%, inclusive, at screening
boolean
C0474680 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fasting plasma glucose <280 mg/dl (15.5 mmol/l)
boolean
C0583513 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) <=45 kg/m2, inclusive, at screening
boolean
C1305855 (UMLS CUI [1])
Diet therapy | Exercise | Metformin Stable | Sulfonylurea Stable | Pioglitazone Stable | Combined Modality Therapy
Item
treated with diet and exercise or a stable regimen of metformin, sulfonylurea, pioglitazone or any 2 of these agents
boolean
C0012159 (UMLS CUI [1])
C0015259 (UMLS CUI [2])
C0025598 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
C0038766 (UMLS CUI [4,1])
C0205360 (UMLS CUI [4,2])
C0071097 (UMLS CUI [5,1])
C0205360 (UMLS CUI [5,2])
C0009429 (UMLS CUI [6])
C0015259 (UMLS CUI [2])
C0025598 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
C0038766 (UMLS CUI [4,1])
C0205360 (UMLS CUI [4,2])
C0071097 (UMLS CUI [5,1])
C0205360 (UMLS CUI [5,2])
C0009429 (UMLS CUI [6])
Pancreatitis | Triglycerides Dose
Item
history of pancreatitis or triglycerides >=500 mg/dl
boolean
C0030305 (UMLS CUI [1])
C0041004 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0041004 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Medullary carcinoma | Multiple Endocrine Neoplasia Type | Family history Medullary carcinoma | Family history of multiple endocrine neoplasia Type
Item
medullary carcinoma or multiple endocrine neoplasia (men2) or a family history of either
boolean
C0206693 (UMLS CUI [1])
C0027662 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C0241889 (UMLS CUI [3,1])
C0206693 (UMLS CUI [3,2])
C4039247 (UMLS CUI [4,1])
C0332307 (UMLS CUI [4,2])
C0027662 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C0241889 (UMLS CUI [3,1])
C0206693 (UMLS CUI [3,2])
C4039247 (UMLS CUI [4,1])
C0332307 (UMLS CUI [4,2])
Cardiovascular Disease
Item
active cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Congestive heart failure
Item
presence of congestive heart failure
boolean
C0018802 (UMLS CUI [1])
Liver disease
Item
liver disease
boolean
C0023895 (UMLS CUI [1])
Gastrointestinal Diseases Severe
Item
history of severe gastrointestinal diseases
boolean
C0017178 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Hypoglycemia Severe Repeated
Item
repeated severe hypoglycemia within the last 6 months
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
exenatide | GLP-1 Analogue
Item
any previous use of exenatide or other glucagon-like peptide-1 (glp-1 ) analog
boolean
C0167117 (UMLS CUI [1])
C3273809 (UMLS CUI [2])
C3273809 (UMLS CUI [2])
Dipeptidyl Peptidase 4 Inhibitors
Item
dipeptidyl peptidase-4 (dpp-4) inhibitor use in the last 3 months
boolean
C2917254 (UMLS CUI [1])